Showing results (101-110 of 121) with videos related to
Sort By:
Pageof 13
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 26, 2021
Development of an EORTC questionnaire measuring instrumental activities of daily living (IADL) in patients with brain tumours: phase I-IIIQuirien Oort, Linda Dirven, Sietske A M Sikkes, et al.The Oncologist|March 10, 2017
Role of MGMT Methylation Status at Time of Diagnosis and Recurrence for Patients with Glioblastoma: Clinical ImplicationsAlba A Brandes, Enrico Franceschi, Alexandro Paccapelo, et al.Neuro-Oncology Practice|July 20, 2022
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient's IADL?Quirien Oort, Linda Dirven, Sietske A M Sikkes, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 5, 2003
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962Philip M P Poortmans, Hanneke C Kluin-Nelemans, Hanny Haaxma-Reiche, et al.Annals of Palliative Medicine|November 12, 2023
Latest clinical research in leptomeningeal disease (LMD)-a narrative reviewAdrian Wai Chan, Henry C Y Wong, Martin Taphoorn, et al.European Journal of Cancer (Oxford, England : 1990)|June 17, 2019
The added value of health-related quality of life as a prognostic indicator of overall survival and progression-free survival in glioma patients: a meta-analysis based on individual patient data from randomised controlled trialsMarijke Coomans, Linda Dirven, Neil K Aaronson, et al.Neuro-Oncology|April 11, 2022
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival periodMarijke B Coomans, Linda Dirven, Neil Aaronson, et al.Neuro-Oncology Practice|December 11, 2020
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patientsMarijke B Coomans, Martin J B Taphoorn, Neil K Aaronson, et al.Neuro-Oncology Practice|July 15, 2024
Inequalities in access to neuro-oncology supportive care and rehabilitation: A survey of healthcare professionals' perspectivesFlorien Boele, Lena Rosenlund, Sara Nordentoft, et al.Neuro-Oncology|November 5, 2019
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?Marijke B Coomans, Linda Dirven, Neil K Aaronson, et al.Pageof 13